Latest Atopy Stories
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct.
DALLAS, October 13, 2014 /PRNewswire/ -- The EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 is a 30 pages market research published in October
Aratana to Develop CRTH2 Antagonist for Atopic Dermatitis in Companion Animals KANSAS CITY, Kan. and OXFORD, United Kingdom, Oct.
Margo Weaver, a Florida-based author, has released a new book aimed at helping children suffering from eczema to become more comfortable in their skin. APOPKA,
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis.
Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
EpiCeram(R) Controlled Release Skin Barrier Emulsion now offers dosing flexibility with 2 sizes SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PuraCap(TM) Pharmaceutical today
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.